Loading market dashboard

Financials in CAD. Standardized financial statements.
A compact view of how MustGrow Biologics Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $8.29M | $398,018 | $4.71M | $6,479 | $12,869 | $0 | $0 | $2,000 | $2,102 | $0 |
| Revenue Growth? | +1982.0% | -91.6% | +72630.4% | -49.7% | 0.0% | 0.0% | -100.0% | -4.9% | 0.0% | 0.0% |
| Cost of Revenue? | $6.87M | $97,263 | $384,685 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $1.41M | $300,755 | $4.33M | $6,479 | $12,869 | $0 | $0 | $2,000 | $2,102 | $0 |
| Gross Margin? | +17.0% | +75.6% | +91.8% | +100.0% | +100.0% | 0.0% | 0.0% | +100.0% | +100.0% | 0.0% |
| Operating Expenses? | $7.66M | $5.41M | $5.52M | $5.69M | $3.02M | $3.37M | $1.47M | $1.86M | $36,451 | $20,443 |
| Operating Income? | -$6.25M | -$5.11M | -$804,988 | -$5.56M | -$3.01M | -$3.37M | -$1.47M | -$1.85M | -$287,188 | -$20,443 |
| EBITDA? | -$6.20M | -$5.11M | -$676,940 | -$5.56M | -$3.01M | -$3.26M | -$1.47M | -$1.85M | -$170,251 | -$147,891 |
| Income Before Tax | -$7.26M | -$4.89M | -$676,940 | -$5.57M | -$3.06M | -$3.31M | -$1.52M | -$1.89M | -$197,564 | -$172,287 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$7.26M | -$4.89M | -$676,940 | -$5.57M | -$3.06M | -$3.36M | -$1.56M | -$1.89M | -$197,564 | -$20,443 |
| EPS? | $-0.13 | $-0.09 | $-0.01 | $-0.11 | $-0.07 | $-0.09 | $-0.06 | $-0.08 | $-0.01 | $-0.00 |
| Diluted EPS? | $-0.13 | $-0.09 | $-0.01 | $-0.11 | $-0.07 | $-0.09 | $-0.06 | $-0.08 | $-0.01 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality